Home
HelpTest Code LAB3947 REFLEX TEST ONLY Factor IX Inhibitor Screen, Plasma
Additional Codes
Mayo test code: F9_IS
Method Name
Only orderable as a reflex. For more information see:
9INHE / Factor IX Inhibitor Evaluation, Plasma
ALUPP / Lupus Anticoagulant Profile, Plasma
ALBLD / Bleeding Diathesis Profile, Limited, Plasma
APROL / Prolonged Clot Time Profile, Plasma
Optical Clot-Based
Reporting Name
Factor IX Inhib ScrnSpecimen Type
Plasma Na CitSpecimen Minimum Volume
2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Plasma Na Cit | Frozen | 14 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | Reject |
| Gross icterus | Reject |
Reference Values
Only orderable as a reflex. For more information see:
9INHE / Factor IX Inhibitor Evaluation, Plasma
ALUPP / Lupus Anticoagulant Profile, Plasma
ALBLD / Bleeding Diathesis Profile, Limited, Plasma
APROL / Prolonged Clot Time Profile, Plasma
Negative
Day(s) Performed
Monday through Friday
Report Available
1 to 3 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
85335
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| F9_IS | Factor IX Inhib Scrn | 30086-3 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 7802 | Factor IX Inhib Scrn | 30086-3 |
Specimen Required
Only orderable as a reflex. For more information see:
9INHE / Factor IX Inhibitor Evaluation, Plasma
ALUPP / Lupus Anticoagulant Profile, Plasma
ALBLD / Bleeding Diathesis Profile, Limited, Plasma
APROL / Prolonged Clot Time Profile, Plasma
For more information see Coagulation Guidelines for Specimen Handling and Processing.
Useful For
Detecting the presence of a specific factor inhibitor directed against coagulation factor IX